Antenatal steroids and thyroid hormone function in preterm infants

J Perinatol. 2018 Nov;38(11):1466-1470. doi: 10.1038/s41372-018-0225-5. Epub 2018 Sep 11.

Abstract

Background: Antenatal steroids (ANS) are used widely for women at risk of preterm delivery. Evidence on the effects of ANS on thyroid hormone function in preterm infants is limited.

Objectives: To determine effects of ANS on thyroid hormone function in preterm infants.

Methods: A retrospective cohort study of preterm infants born before 30 weeks of gestation. Infants were divided into no ANS, partial ANS, and complete ANS groups. Thyroid function tests at day of life 30 were compared.

Results: 260 Infants were included. A significantly higher proportion of patients were started on levothyroxine (LT4) in no ANS group and partial ANS group compared to complete ANS group. Logistic regression analysis revealed that infants in no ANS group are more likely to have TSH > 6 μIU ml-1 and started on LT4 compared to complete ANS group.

Conclusion: Infants in no ANS group are more likely to have thyroid dysfunction compared to complete ANS group.

MeSH terms

  • Adult
  • Female
  • Gestational Age
  • Humans
  • Hypothyroidism / diagnosis*
  • Hypothyroidism / drug therapy
  • Infant, Extremely Premature / blood*
  • Infant, Newborn
  • Infant, Premature, Diseases / prevention & control*
  • Logistic Models
  • Maternal Exposure*
  • Multivariate Analysis
  • Pregnancy
  • Prenatal Care / methods
  • Retrospective Studies
  • Steroids / therapeutic use*
  • Thyroid Function Tests
  • Thyroid Gland / drug effects
  • Thyroid Hormones / blood
  • Thyroxine / therapeutic use
  • Young Adult

Substances

  • Steroids
  • Thyroid Hormones
  • Thyroxine